Ardian in talks to buy Bio 7 from Chequers Capital

Ardian is in exclusive talks to buy a minority stake in the clinical pathology laboratories operator Bio 7 group from fellow private equity firm Chequers Capital. The group operates 56 point-of –care laboratories and three main technical platforms in Essonne, Seine et Marne and Yvelines in France. Chequers bought a stake in Bio 7 alongside …